Nearly 80 percent of reported cases of the Omicron COVID-19 variant in Germany occurred in fully vaccinated individuals, according to a new report from the federal government.
Note: This article has been updated following an error by the German federal government. Following publication, the Robert Koch Institute issued a revision to the report’s figures documenting transmission of the Omicron variant. 1,097 unvaccinated people and 4,020 vaccinated people now comprise the cohort analyzed in the paper. This new data still shows that the overwhelming majority – 78.6 percent – of cases occurred in vaccinated people.
The original report, with appropriate edits, follows:
The paper – published December 30th by the German agency the ‘Robert Koch Institute’ – included information on the vaccination status of 4,206 individuals who contracted the latest variant of the virus.
Four thousand and twenty people who reported contracting Omicron in the study – which equates to 95.6 percent of total cases – had received at least two doses of COVID-19 vaccines. The revised data from the German government revealed a 78.6 percent vaccinated rate of Omicron cases.
Originally, only 186 people contracting Omicron were unvaccinated in the entire sample, showing that vaccinated individuals were over 21 times as likely to contract the COVID-19 variant. The new RKI numbers reported 1,097 unvaccinated people, meaning the vaccinated were 3.7 times more likely to contract the variant.
On December 14th, The National Pulse declared the COVID-19 situation worldwide a “pandemic of the vaccinated”.
The Robert Koch Institute report also documented symptoms for nearly 7,000 individuals who tested positive for Omicron, and the majority of people experienced virtually no adverse effects:
“For 6,788 cases, information on the symptoms was provided, mostly no or mild symptoms were reported. 124 patients were hospitalized, four people died.”
The data – which appears to show that vaccines confer no advantage to preventing against contracting the Omicron variant – follows pharmaceutical companies reaching record high levels of lobbying efforts in America, both financially and in terms of hired personnel.
Amidst heavy censorship of those criticizing the side effects and adverse reactions to the COVID-19 vaccine, The National Pulse has also revealed leading pharmaceutical giant Pfizer Inc.’s conflicts of interest with social media platforms including Facebook and media outlets such as Reuters.
Read the updated report: